Table 4 Performance by modality (CTA vs. TOF-MRA)
Method | CTA (IntrA, CQ500) | TOF-MRA (ADAM) | ||
|---|---|---|---|---|
DSC (%) | FP/case | DSC (%) | FP/case | |
nnU-Net | 76.5 | 1.25 | 75.8 | 1.30 |
Med-MAE | 80.1 | 1.10 | 79.5 | 1.12 |
DG SOTA | 80.8 | 1.12 | 80.0 | 1.18 |
AMAP (ours) | 83.9 | 0.91 | 83.2 | 0.93 |
Method | CTA (IntrA, CQ500) | TOF-MRA (ADAM) | ||
|---|---|---|---|---|
DSC (%) | FP/case | DSC (%) | FP/case | |
nnU-Net | 76.5 | 1.25 | 75.8 | 1.30 |
Med-MAE | 80.1 | 1.10 | 79.5 | 1.12 |
DG SOTA | 80.8 | 1.12 | 80.0 | 1.18 |
AMAP (ours) | 83.9 | 0.91 | 83.2 | 0.93 |